26: The Biden Administration Takes On Tranq

This week, the White House announced a new initiative to tackle the growing use of fentanyl laced with xylazine — known to many as "tranq." This combination of drugs poses an alarming and significant threat to public health. The CDC reported last month that the percentage of fatal opioid overdoses in which xylazine was detected increased by 276% in just three years.

The Baker Institute’s fellow in drug policy, Katharine Neill Harris, discusses the rise in xylazine-laced fentanyl, as well as federal, state, and local policy approaches to curbing the nation’s overdose epidemic. 

Discussants:

• Joe Barnes, Bonner Means Baker Fellow, Baker Institute for Public Policy
• Katharine Neill Harris, Ph.D., Alfred C. Glassell, III, Fellow in Drug Policy, Baker Institute